Healthcare

LD 1899 creates a new deduction for Maine state income tax on medical and dental expenses paid by taxpayers or their spouses/dependents. It allows a deduction for expenses that qualify under federal tax law (Internal Revenue Code), even if they don't meet the federal threshold or weren't claimed on federal returns. The deduction applies to expenses not covered by insurance and is effective for tax years beginning January 1, 2026. This directly affects individual Maine taxpayers who pay for healthcare costs, expanding their state tax relief beyond federal requirements.

LD 544 exempts sales of cannabis for medical use from Maine's sales tax, creating tax parity with prescription medicines. The bill amends Maine's tax code to include medical cannabis sales (after January 1, 2026) under the existing exemption for prescription medicines sold by doctors. It directly affects patients certified for medical cannabis use under Maine's Medical Use of Cannabis Act and providers selling to them. This policy change removes a sales tax burden currently applied to medical cannabis, aligning its tax treatment with other prescribed medicines. The exemption applies only to cannabis sold with a medical provider's certification, not recreational sales.

LD 1333 updates Maine's Paid Family and Medical Leave program to clarify eligibility and administration. It requires employees to have worked for an employer for at least 120 days to qualify, shortens the deadline for filing leave applications from 90 to 30 days after leave begins, and adjusts employer contribution rules: companies with 15+ workers can deduct 50% of premiums from employee wages and send 100% to the fund, while smaller employers send 50%. The bill also specifies that leave under this program runs concurrently with federal FMLA, and defines "self-employed" to include small business owners with fewer than 15 employees. These changes directly affect Maine workers seeking leave and their employers managing contributions.

LD 189 removes the requirement for health care facilities to obtain state approval (a "certificate of need") before offering mental health services or substance use disorder treatment in Maine. This change directly affects facilities providing these services, allowing them to expand or start new programs without waiting for state review. By eliminating this regulatory barrier, the bill aims to increase the availability and affordability of mental health and substance use disorder care for residents. The legislation amends Maine law to specifically exclude these services from the certificate of need process.

LD 219 limits certified hypodermic apparatus exchange programs in Maine to a one-for-one exchange. The bill requires participants to return one used needle to receive one new needle from the program. This change directly affects participants in Maine's certified needle exchange programs and the Maine Center for Disease Control and Prevention, which administers these programs under the updated law. The policy change modifies existing law to ensure participants receive only one new needle per needle they exchange.